Cointime

Surf Bio

company

About

Surf Bio develops therapeutic solutions for diabetes, oncology, infectious diseases, and gene therapy.

  • Palo Alto,California,United States
  • 1 - 10

Highlights

Total Funding Amount
$16M
Funding Rounds
1
Investors
2
Investments
1
Employee Profiles
2

Details

Last Funding Type
Seed
Last Funding Money Raised
$16M
Industries
Biotechnology,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2021
Number Of Employee
1 - 10
Operating Status
Active

Surf Bio is a preclinical biopharmaceutical company leveraging a breakthrough next-generation surfactant to develop enhanced therapeutic solutions for diabetes, oncology, infectious diseases, gene therapy, and other therapeutic areas.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$16M
Surf Bio has raised a total of $16M in funding over 2 rounds. Their latest funding was raised on Apr 12, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 12, 2022 Seed $16M 2 Breakout Ventures
Perceptive Advisors 		— Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Surf Bio has made 1 investments. Their most recent investment was on Apr 27, 2022, when EnsoData raised $20M.
Date Company Name
Round Money Raised Industry Lead Investor
Apr 27, 2022 EnsoData
Series A $20M Analytics —

Investors

Number of Lead Investors
Number of Investors
2
2
Surf Bio is funded by 2 investors. Breakout Ventures and Perceptive Advisors are the most recent investors.
Investor Name Lead Investor Funding Round
Breakout Ventures Yes Seed
Perceptive Advisors Yes Seed

Employee Profiles

Number of Employee Profiles
2
Surf Bio has 2 current employee profiles, including Board member Lindy Fishburne
Lindy Fishburne
Board member
Ben Askew
Board member
Cointime
Содержание
компания